About Cytonics
Cytonics is a company based in Jupiter (United States) founded in 2006 by Gaetano Scuderi.. Cytonics has raised $3.33 million across 8 funding rounds from investors including HHS and NIH SBIR/STTR. The company has 8 employees as of December 31, 2017. Cytonics offers products and services including APIC™ System, FACT™ Diagnostic, and CYT-108. Cytonics operates in a competitive market with competitors including PierianDx, Treos Bio, Circular Genomics, Ignyta and Crescendo Bioscience, among others.
- Headquarter Jupiter, United States
- Employees 8 as on 31 Dec, 2017
- Founders Gaetano Scuderi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytonics Corporation
-
Annual Revenue
$417.5 K3as on Dec 31, 2023
-
Net Profit
$-2.84 M-48as on Dec 31, 2023
-
EBITDA
-
Total Equity Funding
$3.33 M (USD)
in 8 rounds
-
Latest Funding Round
$25 K (USD), Seed
Jun 07, 2019
-
Investors
HHS
& 1 more
-
Employee Count
8
as on Dec 31, 2017
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytonics
Cytonics offers a comprehensive portfolio of products and services, including APIC™ System, FACT™ Diagnostic, and CYT-108. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Autologous treatment using A2M to reduce osteoarthritis pain and inflammation
Test that detects cartilage damage in joint fluid for patient diagnosis
Recombinant A2M therapy aimed at improving cartilage protection in osteoarthritis
Unlock access to complete
Unlock access to complete
Funding Insights of Cytonics
Cytonics has successfully raised a total of $3.33M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $25 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Seed — $25,000
-
First Round
First Round
(18 May 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Seed - Cytonics | Valuation |
investors |
|
| Nov, 2012 | Amount | Grant - Cytonics | Valuation |
investors |
|
| May, 2011 | Amount | Grant - Cytonics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytonics
Cytonics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytonics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytonics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytonics Comparisons
Competitors of Cytonics
Cytonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PierianDx, Treos Bio, Circular Genomics, Ignyta and Crescendo Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic tests for individualized disease diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Developer of cancer vaccines and companion diagnostics
|
|
| domain | founded_year | HQ Location |
RNA-based diagnostics and therapeutics for depression are developed and provided.
|
|
| domain | founded_year | HQ Location |
Personalized medicine is developed for cancer and autoimmune diseases.
|
|
| domain | founded_year | HQ Location |
Molecular tests for autoimmune and inflammatory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Biological drug monitoring and molecular diagnostics are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytonics
Frequently Asked Questions about Cytonics
When was Cytonics founded?
Cytonics was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is Cytonics located?
Cytonics is headquartered in Jupiter, United States. It is registered at Jupiter, Florida, United States.
Who is the current CEO of Cytonics?
Joey Bose is the current CEO of Cytonics.
Is Cytonics a funded company?
Cytonics is a funded company, having raised a total of $3.33M across 8 funding rounds to date. The company's 1st funding round was a Grant of $1.6M, raised on May 18, 2009.
How many employees does Cytonics have?
As of Dec 31, 2017, the latest employee count at Cytonics is 8.
What is the annual revenue of Cytonics?
Annual revenue of Cytonics is $417.5K as on Dec 31, 2023.
What does Cytonics do?
Cytonics was founded in 2006 in Jupiter, United States, within the biotechnology sector. Focus is placed on developing diagnostics and therapeutics for osteoarthritis. The flagship product, the Fibronectin-Aggrecan Complex Test (FACT), is utilized to detect cartilage damage from patients joint fluid samples. Operations center on advancing treatments and early detection methods for joint-related conditions.
Who are the top competitors of Cytonics?
Cytonics's top competitors include Circular Genomics, PierianDx and Ignyta.
What products or services does Cytonics offer?
Cytonics offers APIC™ System, FACT™ Diagnostic, and CYT-108.
Who are Cytonics's investors?
Cytonics has 2 investors. Key investors include HHS, and NIH SBIR/STTR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.